Inhibitory effects of anti-sense PTTG on malignant phenotype of human ovarian carcinoma cell line SK-OV-3

Abstract

To construct cukaryotic expression vector expressing full length anti-sense pituitary tumor transforming gene (PTTG) mRNA and observe its blocking effect on the potential invasion of human ovarian carcinoma cell line SK-OV-3. PCR primers containing designed enzyme cut sites were used for cloning full-length PTTG gene fragment, and the resulting PCR product was inserted into the eukaryotic vector pcDNA3. 1 in the antisense direction. The recombinant vector was then transfected into SK-OV-3 by Lipofectamine. The positive cell clone was screened by G418, PTTG and hFGF at protein level expression were detected by Western blot. The biological behavior change of transfection positive cells was observed by colony formation in soft agar assay. Our results showed that SK-OV-3 clones stably expressing full-length recombinant pcDNA3. 1-PTTGas were obtained. The expressions of PTTG and bFGF protein in transfected cells were decreased by 61.5 % and 52.3%, respectively as compared with non-transfected ones. The number of colony formation was reduced significantly in transfected cells as compared with empty vector transfected and non transfected cells. It is concluded that the recombinant vector pcDNA3. 1-PTTGas is a novel tool and provides an alternative anti-sense gene therapy targeted at PTTG in human carcinoma.

Keywords

PTTG / ovarian carcinoma / anti-sense nuclei acid

References

[1] LinP, ShiomoM. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endo Mol Endocrinol, 1997, 4433-433

[2] ZhangX, HorwitzG A, PrezantT R, et al. . Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol, 1999, 13(1): 156-156

[3] SitouZ, WuJ Z. Cell Cultur, 1996, Xian, World Publishing Corp.: 184-186

[4] DominguezA, Ramos-MoralesF, RomeroF, et al. . hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene, 1998, 17(17): 2187-2187

[5] HeaneyA P, SingsonR, McCabeC J, et al. . Expression of pituitary-tumour transforming gene in colorectal tumors. Lancet, 2000, 355(9205): 716-716

[6] SaezC, JaponM A, Ramos-MoralesF, et al. . hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene, 1999, 18(39): 5473-5473

[7] ZouH, McGarryT J, BernalT, et al. . Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science, 1999, 285(5426): 418-418

[8] PuriR, ToussonA, ChenL, et al. . Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Lett, 2001, 163(1): 131-131

[9] HeaneyA P, MelmedS. New pituitary oncogenes. Endocri Relat Cancer, 2002, 73-3

[10] FolkmanJ, KlagsbrunM. Angiogenic factors. Science, 2002, 232442-2442